Managing treatment-related peripheral neuropathy in patients with multiple myeloma
Sara Grammatico, Laura Cesini, Maria Teresa Petrucci Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy Abstract: Peripheral neuropathy is one of the most important complications of multiple myeloma treatment. Neurological damage can be o...
Main Authors: | Grammatico S, Cesini L, Petrucci MT |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-06-01
|
Series: | Blood and Lymphatic Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/managing-treatment-related-peripheral-neuropathy-in-patients-with-mult-peer-reviewed-article-BLCTT |
Similar Items
-
Incidence, characteristics, and treatments of peripheral neuropathy in multiple myeloma patients receiving bortezomib (velcade)
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01) -
Prevention and management of bortezomib-induced peripheral neuropathy in patients with multiple myeloma
by: S. V. Semochkin, et al.
Published: (2022-04-01) -
Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
by: Ines Klein, et al.
Published: (2021-09-01) -
Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development
by: Karolina Łuczkowska, et al.
Published: (2022-02-01) -
Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes
by: Sebastian W. Nielsen, et al.
Published: (2022-03-01)